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Raman and fluorescence spectroscopy methods are 
being considered as techniques which could be com-
plementary or even alternative to biopsy, and patho-
logy and clinical assays in many medical applications. 
The present paper discusses the results of Raman 
spectral studies on oral tissues for optical pathology. It 
is shown that Raman spectra of oral tissues can be 
classified into spectra of normal and malignant sets 
and a model based on such a classification can be used 
to analyse oral tissue for detection of oral malignancy. 
Sensitivity and specificity calculated from 90 test spec-
tra are better than 85 and 90 per cent respectively. 
AT present many disease conditions, and almost all cases 
of cancer are diagnosed by subjecting a biopsied tissue 
sample to pathological examination. Vigorous research is 
going on at present1–3 in finding whether optical spectro-
scopy methods like Raman, FTIR and fluorescence can be 
employed for such diagnostic applications, especially in 
areas like early detection of cancer. In our laboratory, we 
have studied Raman spectra of normal as well as diff rent 
stages of malignant oral tissues and have developed a 
Raman spectroscopy technique for optical pathology of 
oral tissue. To the best of our knowledge, that is the first 
time such a detailed analysis of sufficiently large number 
of samples has been carried out to prove the efficacy of 
the use of Raman spectroscopy for optical pathology in 
oral cancer. The Raman spectra have also led to identifi-
cation of the biochemical changes in the two types of  
tissues. The results are presented and discussed n 
this paper. 
 Oral tissue samples obtained by biopsy (25) or surgical 
resection (24) were supplied by the College of Dental 
Surgery and Sai Baba Cancer Hospital, Manipal, India. Of 
these, 37 were squamous cell carcinoma and rest were 
normal, obtained from the same group of patients. More 
than 140 spectra were recorded using different sites on 
these samples. Raman spectra of the samples, kept moist 
with saline, were recorded within half an hour of tissue 
removal, though trial runs have shown that the spec ra 
remain unchanged even for several hours after biopsy, if 
kept in saline. For each sample, spectra were recorded 
from several points, separated by few hundred microns to 
few millimetres. All standard chemicals were obtained 
from Sigma Chemical Co. and use as such. 
 Spectra were recorded on a Spex Triax 320 spectro-
meter equipped with a Spectrum One liquid N2 cooled, 
CCD detector, and 600 g/mm (900 nm blazed) grating. 
Excitation was with a 785 nm diode laser (SDL 8530) 
with laser power of 100– 5  mW. A holographic filter 
(Kaiser Optics) was used to remove the background emi-
ssion from the laser and a notch filter (Kaiser Optics) was 
used in the collimated scattered beam to reduce the laser 
background. 
 Figure 1 shows typical spectra of normal and malignant
buccal mucosa samples. Even a visual examination of the 
spectra is sufficient to discriminate between the normal 
and malignant specimens. In general, the spectrum of 
normal oral tissue is closer to the lipid spectrum, while 
the spectrum of malignant samples resembles the spec-
trum of proteins. Figure 2 shows the Raman spectra across 
a ample which had been diagnosed pathologically as  
malignant at the centre, the edges being normal. It can be 
seen that the spectral characteristics change from mali-
gnant to normal as we scan across the sample. It is thus 
clear that for many medical and surgical applications like 
screening of general population, decision of surgical 
boundaries, follow up for regression or recurrence and 
progress during therapy, Raman spectra can be success-
fully used as a routine probe. With a fibre optic probe, 
spectra can be obtained in situ in a few minutes and this 
facilitates all the applications mentioned above. A biopsy 
followed by pathological examination is not so convenient 
in all the above cases, because of the need to remove and 
examine the tissue, which takes considerable time. 
 In the present study we have collected more than 140 
spectra and these have been analysed to derive statisti-
cally significant quantitative information about the spec-
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Figure 1. Raman spectra of buccal mucosa: a, Normal; b, malignant. 
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tral components. This was done by carrying out a principal 
component analysis (PCA) of the various sets of spectra, 
and the derived spectral and statistical parameters4–6 have 
given quantitative information on the samples.
 I  PCA, spectra from a sufficiently large number of 
amples, which belong to a given class (for example nor-
mal oral tissue) are subjected to an eigenvalue–eigen- 
vector analysis. The entire spectral data from all standard 
samples are first used in calculating a set of eigenvectors 
and scores. The eigenvectors can be considered as  
the spectral equivalents of the principal components (or 
factors) of the samples, while the scores correspond to the 
contribution of each principal component to a given  
sample. Each sample spectrum can be regenerated by 
multiplying the eigenvectors with the scores for that 
sample and adding the products for all scores. The spectra 
of a given set of samples may have contribution only from 
a limited number of factors and many of the eigenvalues 
may be close to zero with no practical contribution to the 
spectra. The number of significant factors can be decided 
by several techniques5,7. Figure 3 a shows the eigen-  
values for the factors and total per cent variance (i.e. total 
percentage contribution to the spectra with increasing 
number of factors) for 25 spectra of normal oral tissue, 
while Figure 3b shows the same for a set of malignant 
tissue spectra. It is seen that the eigenvalues decrease  
very rapidly and are almost zero after 6–7 factors, and 
about 99% of the total spectral contribution come from 
these factors. Figure 4 shows the ‘spectral’ contribution of 
the first, second, eighth and ninth factors for normal  
tissue. It can be seen that the spectral loading (contribu-
tion) of factors eight and ni e simple compensates only 
for the noise in the spectra, and need not be included in 
any assessment. This can be further confirmed by using an 
appropriate number of factors from the model set and  
regenerating the spectrum of any sample. The difference 
between the observed and regenerated spectrum,  
expressed as residual errors squared sum can be used as a 
measure of the desired number of factors, as well as the 
accuracy of the model. Figure 5 shows such a regenerated 
Figure 2. Raman spectra recorded across a surgically resected sample. 
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Figure 3. PCA eigenvalues and total per cent variance (see text) for a 
model set of (a), 25 normal tissue samples and (b), 25 malignant tissue 
samples. Arrows indicate the number of PCA factors required to fit the 
spectra well.  
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Figure 4. Spectral loading of PCA factors for model set of normal 
tissue samples. a, Factor 1; b, factor 2; c, factor 8; and d, factor 9. 
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spectrum for one sample with the corresponding residual 
spectrum, using only the first five factors of the PCA. The 
fit is seen to be excellent. 
 The advantage of PCA is that once a set of spectra have 
been analysed and classified as belonging to a particular 
class, any new spectrum can be compared with this model 
to decide whether it will fit into that class. A new tissue 
sample spectrum can thus be objectively classified as 
normal or malignant (or anywhere between) by comparing 
it with the standard models for normal and malignant 
spectra obtained from pathologically classified normal 
and malignant samples. The statistical significance of 
such a decision can be quantified by various parameters. 
We have employed the Mahalanobis distance7 (M-
distance) and the residual errors squared sum (spectral 
residual) as the criteria. The M-distance for a sample is a 
function of the scores for that sample when compared to a 
model set and will thus clearly show whether that sample 
belongs to the model set, with well-defined statistical 
probability. Figure 6 shows a plot of the M-distance 
against residual errors squared sum for a new set of about 
90 samples, compared to a model set of malignant spec-
tra. It is seen that all samples diagnosed as malignant by 
pathological examination in the new set fall in the lower
left-hand corner of the plot. If we take an M-distance of 1 
as acceptance, then almost all the malignant samples fall 
within 3 times this value, while all samples classified as 
normal lie far outside. The sensitivity and specificity of 
the technique is thus quite good. A closer examination of 
Figure 6 shows a very small number of samples outside 
the acceptable range of either normal or malignant spe-
cies. This might have happened because these samples 
belong to borderline cases, and only long-term follow up 
can classify them correctly. We are doing this at present. 
The sensitivity and specificity based on 90 test spectra are 
better than 85 and 90 per cent, respectively. 
 In addition to being a diagnostic tool, Raman spectro-
scopy can give considerable informati n on the biochemi-
cal molecular composition of the samples. Table 1 shows 
he assignments of the Raman bands from general consi-
derations of infrared and Raman spectral studies8,9. Thes  
assignments show that in general the spectra of normal 
tissue samples resemble those of lipids (C=C, C=O, C– ), 
while the malignant tissue samples resemble protein spec-
tra (amide I, amide II, phenylalanine). 
 There may be several reasons for the observed spectral 
differences between normal and malignant tissue samples. 
We have to note that the spectra were recorded using 
785 nm excitation. Radiation of this wavelength can pene-
trate deep into the tissue, so that several layers of the 
ti sue (e.g. epidermis, dermis, and subcutaneous tissue for 
skin) are exposed to the laser. Similarly, the longer wave-
length Raman scattered light also can exit out even from 
deep inside (several hundred microns) the tissue. Since 
the composition of major cellular materials is not very 
different from normal to malignant cells, the observed 
spectral differences cannot arise only from such small 
com ositional differences and other reasons may exist for 
the observed differences. 
 In all our experiments the laser beam is usually focused 
onto the surface of the sample. The fraction of the radia-
tion which penetrates into the tissue is highly scattered, 
since the scattering coefficient for tissue is very large 
compared to the absorption coefficient10 at our excitation 
wavelength. As a result, any radiation which penetrates 
into th tissue, as well as any scattering from inside the 
tissue is lost to the observation system, having been scat-
tered far away from the collection optics. In tissue sys-
tems, it is thus the surface species which contribute 
significantly to the observed Raman spectrum. It is well 
known that  cells which are malignant or have lost growth 
control by some means have associated with their external 
membrane, a broad variety of receptor-type molecules, 
which are mostly glycoproteins11. Also normal tissue con-
Figure 6. Classification of 88 spectra (44 malignant, 44 normal) 
compared to the model set of malignant spectra. A Mahalanobis dis-
tance up to 3 can be considered as malignant. (Inset) Normal samples 
which lie far out on the plot. 
 
Figure 5. Observed and regenerated spectra using 5 factors, with the 
residual shown below. The spectrum appearing slightly more noisy is 
the observed one. 
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sists of well-differentiated and architecturally highly  
ordered group of cells which present a regular assembly 
of bilayer membranes to the laser beam. On the other 
hand, malignant tissues consist of anaplastic cells with no 
recognizable pattern of orientation. Moreover, the stroma 
made up of connective tissue is crucial to the growth of 
neoplasm. Many cancer cells induce a dense, abundant, 
fibrous stroma (desmoplasia), which will enhance the 
spectrum of the corresponding fibrous component, namely 
collagen-like protein. These two factors may contribute to 
the differences in the Raman spectra of normal and malig-
nant oral tissues. We are now carrying out biochemical 
analyses, as well as scattering model calculations to  
understand more about the spectral difference between 
normal and malignant tissue samples. 
 Several studies indicate the potential of laser-induced 
fluorescence (LIF) to distinguish between normal and 
malignant tissues12–15. But it is not easy to extract bio-
chemical information from the broad fluorescence bands, 
whereas Raman spectra, a seen from Table 1, easily give 
such information which makes it more suitable for diag-
nostic purposes. With present-day advances in instrumen-
tation, Raman spectroscopy is comparable in sensitivity to 
fluorescence16 and hence it can be used routinely for  
diagnostic applications. 
 Raman spectroscopy can be routinely used for optical 
pathology of oral tissue to diagnose malignancy. The tech-
nique is fast, can be applied in situ and combined with 
data pr cessing algorithms, can be made highly objective. 
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Table 1. Assignment of Raman bands in oral tissue 
   
   
Raman shift (cm–1) 
 
Normal  
tissue 
Squamous cell  
carcinoma 
 
 
 
  Assignment 
 
 
 
 Change from normal to malignant 
        
3008 VW   – =C–H stretch (lipid) Disappears 
  – 2998 VW CH stretch (protein) Appears new 
  – 2979 sh, W   ”   ” 
2956 sh, W   – Asym. CH3 (lipid) Disappears 
2936 sh, ms   – a-CH2 (lipid)   ” 
  – 2928 vs CH (protein) Weak in normal 
2894 vs, b 2896 s, sh CH (lipid, protein)   – 
2859 vs, sp   – CH2 sym (lipid) Very weak in malignant 
1744 m, sp   – C=O (lipid) Not observed in malignant 
1656 s, sp 1656 s, b C=C (lipid); amide I (protein) Broader and stronger in malignant 
  – 1609 W Aromatic amino acid (protein)  
  – 1445 s CH2 deformation (protein) Appears in malignant 
1440 vs, sp   – CH2 deformation (lipid) Disappears in malignant 
  – 1339 s CH bend (protein) Appears in malignant 
  – 1332 m CH2 bend (protein) Not observed in normal 
1330 vs, sp   – CH2 twist (lipid) Very weak in malignant 
  – 1273 m Amide III (protein) Not observed in normal 
1268 m, sp   – =CH in plane (lipid) Overlapped by amide III in malignant 
  – 1210 VW, sh Not present in normal 
  – 1172 VW 
Aromatic amino  
acid (protein)   ” 
  – 1129 VW, sp C–N (protein)  
1120 W, sh   – 
1080 s   – 
1071 W, sh   – 
Skeletal  
C–C  
(lipids) 
Not observed  
in malignant 
  – 1004 m, sp Phenylalanine (protein) Not observed in normal 
  – 946 w, sp C–C (protein)   ”     
    
VW, Very weak; W, Weak; sh, Shoulder; s, Strong; b, Broad; m, Medium, sp, Sharp. 
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The present work was undertaken to use green fluo-
rescent protein marker to monitor population of 
Rhizobium transformant in low-cost carriers in com-
parison with lignite. The viability of the R izobium
transformant carrying the reporter gene gfp, was 
studied in four different bioinoculant carriers at vari-
ous temperatures. The viable count of Rhizobium
transformant was minimum in groundnut shell carrier 
and maximum in lignite, at all temperatures. Lignite 
was used as a standard carrier to assess suitability of 
three available low-cost carriers, viz. paddy husk, 
sawdust and crushed groundnut shells. These low-cost 
carriers are byproducts of agro-based industries. In 
this study attempts have been made to use these  
byproducts as carriers, thus exploiting the wastes to 
their full potential. Paddy husk proved to be a good 
protective material compared to sawdust and crushed 
groundnut shells at all temperatures. The reporter 
gene, gfp, can be used as marker for monitoring the 
bioinoculants. 
SCIENTISTS have typically relied on antibiotic resistance 
as the marker for their introduced micro-organisms. By 
culturing field samples on media containing the appro-
priate antibiotics or other selective agents, selection and 
enumeration of the introduced bacterium resistant to the 
selective agent are often possible1–3. This popular tech-
nique is simple, rapid, selective, and inexpensive and has 
been used successfully with samples from various environ-
ments. There are, however, several drawbacks to this  
approach, since there frequently exists high background 
microbial populations resistant to the antibiotics used as 
selective agents, the limit of detection may be unaccepta-
bly high4. Researchers are trying for unambiguous meta-
bolic and/or physical markers. 
In recent years, molecular tools have been developed to 
identify and quantify specific microbial cells or specific 
microbial activities in mixed populations. These tools are 
especially valuable for analysis of specific bacteria in 
complex environmental samples. Increasingly, research 
has concentrated on the development of marker genes for 
tagging a particular bacterial species of interest, so that 
the cells can be specifically identified and monitored5–7. 
For example, the genes encoding bacterial Luciferase 
(Lux AB) or firefly Luciferase (Luc) have been found to 
be very useful markers, since tagged cells can be detected 
on the basis of their bioluminescent phenotype. Other 
example of genes specifically used to mark bacteria  
include metabolic markers, such as Lac ZY (b-galacto-
sidase and lactose permease), Gus A (b-glucuronidase), 
and xylE (2,3-catechol deoxygenase), which are detected 
on the basis of unique coloured products formed after 
growth of the cells on specific media8–10. 
There was a tremendous burst of interest in the scien-
tific community when the gene encoding green fluorescent 
protein, gfp, from jellyfish Aequorea victoria, was cloned 
and expressed in Escherichia coli and in a range of cell 
types. An advantage of gfp is that, unlike other bio-
markers, it does not require any substrate or additional 
cofactors for fluorescence11. 
Peat and soil rich in organic matter are generally used 
in the preparation of legume inoculants and constitute a 
suitable carrier for the purpose12. For the execution of 
healthy inoculation practice, besides manufacturing effi-
cient Rhizobium inoculants, it is equally important to 
maintain the viability of Rhizobium cells at a satisfactory 
level for a longer period of storage. Some works related 
to different factors affecting longevity of rhizobial cells, 
e.g. temperature, moisture and carriers have been carried 
out. Peat possesses a privileged position in the manufac-
turing of legume inoculants because of many advantages 
associated with it. However, there are no large-scale  
deposits of peat in India and therefore any commercial 
exploitation seems to be a remote possibility. Lignite is 
now regarded as a standard carrier, and also adopted for 
commercial production of legume inoculants, as well as 
for other nitrogen-fixing cultures in India. 
The present communication deals with use of green 
fluoresc nt protein (GEP) marker to study viability of 
Rhizobium in low-cost carriers, viz. paddy husk, sawdust 
and groundnut shells in comparison with standard lignite 
carrier. *For correspondence. (e-mail: bpkap@unipune.ernet.in) 
